Evidence map›Paper›PMID 39941696›Full record

ReviewJournal of clinical medicine2025

Exploring the Therapeutic Potential of

Wilson R Tavares, Ana M L Seca, Maria Carmo Barreto

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wilson R TavaresUniversity of the Azores, Faculty of Sciences and Technology, Centre for Ecology, Evolution and Environmental Changes (cE3c), Azorean Biodiversity Group & Global Change and Sustainability Institute (CHANGE), 9501-321 Ponta Delgada, Portugal.ORCID 0000-0001-9817-2756
Ana M L SecaUniversity of the Azores, Faculty of Sciences and Technology, Centre for Ecology, Evolution and Environmental Changes (cE3c), Azorean Biodiversity Group & Global Change and Sustainability Institute (CHANGE), 9501-321 Ponta Delgada, Portugal.ORCID 0000-0002-7709-2375
Maria Carmo BarretoUniversity of the Azores, Faculty of Sciences and Technology, Centre for Ecology, Evolution and Environmental Changes (cE3c), Azorean Biodiversity Group & Global Change and Sustainability Institute (CHANGE), 9501-321 Ponta Delgada, Portugal.ORCID 0000-0001-5797-8913

Funding

DRCT - Azores Regional Government M3.1.a/F/029/2022Fundação para a Ciência e Tecnologia FCT-UIDB/00329/2020-2024Fundação para a Ciência e Tecnologia UIDB/50006/2020 and UIDP/50006/2020
6 · The paper itself

Abstract

Metabolic syndrome, a cluster of metabolic disorders comprising dyslipidemia, insulin resistance, elevated blood pressure, and abdominal obesity, is a silent epidemic that may lead to outcomes such as cardiovascular disease, diabetes, and cancer. Due to the increase in the prevalence of these pathologies, the search for better treatments and more efficient drugs is imperative. Species of

Indexed as

anticancerArtemisiacardiovascular diseasesclinical trialdiabetesdyslipidemiametabolic disordersSalviaSalvia miltiorrhiza depside salt

Identifiers

PMID39941696
PMCPMC11818717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.